Literature DB >> 8100231

An activated allele of the c-erbB-2 oncogene impairs kidney and lung function and causes early death of transgenic mice.

E Stöcklin1, F Botteri, B Groner.   

Abstract

The pathogenicity of the human c-erbB-2 oncogene was evaluated in transgenic mice. A DNA sequence comprising the promoter-enhancer region of the MMTV LTR and a constitutively activated allele of the human c-erbB-2 growth factor receptor gene was introduced into the germ line of mice. Expression of the transgene was observed in kidney, lung, mammary gland, salivary gland, Harderian gland, and in epithelial cells of the male reproductive tract. All transgenic mice expressing the c-erbB-2 receptor died within four months of birth. Histopathological analysis suggests that preneoplastic lesions in kidney and lung most likely caused organ failure and the early death of the transgenic mice. Focal dilatation and atypical proliferation of the tubular epithelial cells was found in the kidney. These hyperplastic lesions were found adjacent to normal tubules. Immunohistochemistry showed that normal renal structures were completely negative for c-erbB-2 protein expression. Atypical pseudopapillary proliferation of bronchial and bronchiolar epithelial cells narrowed the bronchial lumen in lung. Alveoli appeared normal. The expression of c-erbB-2 protein was strictly limited to the proliferating epithelial cells and not detected in normal tissue. The mammary glands of two parous mice were underdeveloped, lacking lobular-alveolar structures and were lactation deficient. Only a few ducts were interspersed in the fat pad. A virgin mouse developed a focal adenocarcinoma infiltrating the mammary fat pad. Expression of the c-erbB-2 protein was enhanced in the proliferating epithelial cells. Transgenic males were sterile. Epithelial hyperplasia and hypertrophy in the epididymis, vas deferens and seminal vesicles was found. The transgene is not uniformly expressed in the tissues where the MMTV LTR is transcriptionally active. The scattered transgene expression invariably coincides with epithelial hyperplasia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8100231      PMCID: PMC2119603          DOI: 10.1083/jcb.122.1.199

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  59 in total

Review 1.  Signal transduction by receptors with tyrosine kinase activity.

Authors:  A Ullrich; J Schlessinger
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

2.  Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.

Authors:  C I Bargmann; M C Hung; R A Weinberg
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

3.  Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo.

Authors:  E Sinn; W Muller; P Pattengale; I Tepler; R Wallace; P Leder
Journal:  Cell       Date:  1987-05-22       Impact factor: 41.582

4.  Oncogenicity of the ret transforming gene in MMTV/ret transgenic mice.

Authors:  T Iwamoto; M Takahashi; M Ito; M Hamaguchi; K Isobe; N Misawa; J Asai; T Yoshida; I Nakashima
Journal:  Oncogene       Date:  1990-04       Impact factor: 9.867

5.  Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development.

Authors:  A Leder; P K Pattengale; A Kuo; T A Stewart; P Leder
Journal:  Cell       Date:  1986-05-23       Impact factor: 41.582

6.  The carboxy-terminal domains of erbB-2 and epidermal growth factor receptor exert different regulatory effects on intrinsic receptor tyrosine kinase function and transforming activity.

Authors:  P P Di Fiore; O Segatto; F Lonardo; F Fazioli; J H Pierce; S A Aaronson
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

7.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

Authors:  D J Slamon; G M Clark; S G Wong; W J Levin; A Ullrich; W L McGuire
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

8.  Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene.

Authors:  L Coussens; T L Yang-Feng; Y C Liao; E Chen; A Gray; J McGrath; P H Seeburg; T A Libermann; J Schlessinger; U Francke
Journal:  Science       Date:  1985-12-06       Impact factor: 47.728

9.  The hormone response element of the mouse mammary tumour virus DNA mediates the progestin and androgen induction of transcription in the proviral long terminal repeat region.

Authors:  A C Cato; D Henderson; H Ponta
Journal:  EMBO J       Date:  1987-02       Impact factor: 11.598

10.  The v-mos and H-ras oncogene expression represses glucocorticoid hormone-dependent transcription from the mouse mammary tumor virus LTR.

Authors:  R Jaggi; B Salmons; D Muellener; B Groner
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

View more
  15 in total

1.  Lipocalin 2 is essential for chronic kidney disease progression in mice and humans.

Authors:  Amandine Viau; Khalil El Karoui; Denise Laouari; Martine Burtin; Clément Nguyen; Kiyoshi Mori; Evangéline Pillebout; Thorsten Berger; Tak Wah Mak; Bertrand Knebelmann; Gérard Friedlander; Jonathan Barasch; Fabiola Terzi
Journal:  J Clin Invest       Date:  2010-11       Impact factor: 14.808

2.  Targeted expression of a dominant-negative EGF-R in the kidney reduces tubulo-interstitial lesions after renal injury.

Authors:  F Terzi; M Burtin; M Hekmati; P Federici; G Grimber; P Briand; G Friedlander
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

3.  Perturbation of beta1-integrin function alters the development of murine mammary gland.

Authors:  M M Faraldo; M A Deugnier; M Lukashev; J P Thiery; M A Glukhova
Journal:  EMBO J       Date:  1998-04-15       Impact factor: 11.598

Review 4.  Genetic manipulation of mammary epithelium by transplantation.

Authors:  P A Edwards; C L Abram; J M Bradbury
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-01       Impact factor: 2.673

5.  Effective antibody therapy induces host-protective antitumor immunity that is augmented by TLR4 agonist treatment.

Authors:  Shangzi Wang; Igor A Astsaturov; Catherine A Bingham; Kenneth M McCarthy; Margaret von Mehren; Wei Xu; R Katherine Alpaugh; Yong Tang; Bruce A Littlefield; Lynn D Hawkins; Sally T Ishizaka; Louis M Weiner
Journal:  Cancer Immunol Immunother       Date:  2011-08-13       Impact factor: 6.968

6.  JunD protects against chronic kidney disease by regulating paracrine mitogens.

Authors:  Evangéline Pillebout; Jonathan B Weitzman; Martine Burtin; Carla Martino; Pierre Federici; Moshe Yaniv; Gérard Friedlander; Fabiola Terzi
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

7.  Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells.

Authors:  Yi Li; Bryan Welm; Katrina Podsypanina; Shixia Huang; Mario Chamorro; Xiaomei Zhang; Tracey Rowlands; Mikala Egeblad; Pam Cowin; Zena Werb; Lee K Tan; Jeffrey M Rosen; Harold E Varmus
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-10       Impact factor: 11.205

Review 8.  Genetically engineered mouse models of mammary intraepithelial neoplasia.

Authors:  R D Cardiff; D Moghanaki; R A Jensen
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

Review 9.  The role of the EGF family of ligands and receptors in renal development, physiology and pathophysiology.

Authors:  Fenghua Zeng; Amar B Singh; Raymond C Harris
Journal:  Exp Cell Res       Date:  2008-08-19       Impact factor: 3.905

Review 10.  The epidermal growth factor receptor pathway in chronic kidney diseases.

Authors:  Laura R Harskamp; Ron T Gansevoort; Harry van Goor; Esther Meijer
Journal:  Nat Rev Nephrol       Date:  2016-07-04       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.